Target (CBDY) Construction in Progress (2018 - 2019)

Target (CBDY) reported Construction in Progress of $8.8 million for Q2 2019, up 38.35% quarter-over-quarter from $6.4 million in Q1 2019.

Target (CBDY) Construction in Progress (2018 - 2019) Analysis & Trends

Target (CBDY) has 2 years of Construction in Progress data on file, last reported at $8.8 million in Q2 2019.

  • Construction in Progress for Q2 2019 came in at $8.8 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2019 was $8.8 million (changed N/A YoY), and the FY2018 annual result was $2.6 million, changed N/A from the prior year.
  • Construction in Progress advanced to $8.8 million in Q2 2019 per CBDY's latest filing, from $6.4 million in the prior quarter.
  • Over five years, Construction in Progress peaked at $8.8 million in Q2 2019 and troughed at $1.2 million in Q3 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Target - - 191,787.00 -

Historic Data

Download Data
DateValue
Jun 30, 2019 8.82 Mn
Mar 31, 2019 6.38 Mn
Dec 31, 2018 2.60 Mn
Sep 30, 2018 1.21 Mn